Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Squalamine aminosterol: Phase I/II

Preliminary analysis of an open-label, Mexican Phase I/II trial in 40 patients with classic or occult

Read the full 169 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE